391 related articles for article (PubMed ID: 34131404)
1. The Impact of TRPV1 on Cancer Pathogenesis and Therapy: A Systematic Review.
Li L; Chen C; Chiang C; Xiao T; Chen Y; Zhao Y; Zheng D
Int J Biol Sci; 2021; 17(8):2034-2049. PubMed ID: 34131404
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.
Wong GY; Gavva NR
Brain Res Rev; 2009 Apr; 60(1):267-77. PubMed ID: 19150372
[TBL] [Abstract][Full Text] [Related]
3. TRPV1 signaling: mechanistic understanding and therapeutic potential.
Xia R; Samad TA; Btesh J; Jiang LH; Kays I; Stjernborg L; Dekker N
Curr Top Med Chem; 2011; 11(17):2180-91. PubMed ID: 21671876
[TBL] [Abstract][Full Text] [Related]
4. Disease-related changes in TRPV1 expression and its implications for drug development.
Premkumar LS; Bishnoi M
Curr Top Med Chem; 2011; 11(17):2192-209. PubMed ID: 21671875
[TBL] [Abstract][Full Text] [Related]
5. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.
Szallasi A; Cortright DN; Blum CA; Eid SR
Nat Rev Drug Discov; 2007 May; 6(5):357-72. PubMed ID: 17464295
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.
De Petrocellis L; Moriello AS
Recent Pat CNS Drug Discov; 2013 Dec; 8(3):180-204. PubMed ID: 24330123
[TBL] [Abstract][Full Text] [Related]
7. TRPV1-Targeted Drugs in Development for Human Pain Conditions.
Iftinca M; Defaye M; Altier C
Drugs; 2021 Jan; 81(1):7-27. PubMed ID: 33165872
[TBL] [Abstract][Full Text] [Related]
8. TRPV1 Ion Channel: Structural Features, Activity Modulators, and Therapeutic Potential.
Gladkikh IN; Sintsova OV; Leychenko EV; Kozlov SA
Biochemistry (Mosc); 2021 Jan; 86(Suppl 1):S50-S70. PubMed ID: 33827400
[TBL] [Abstract][Full Text] [Related]
9. Epithelial TRPV1 signaling accelerates gingival epithelial cell proliferation.
Takahashi N; Matsuda Y; Yamada H; Tabeta K; Nakajima T; Murakami S; Yamazaki K
J Dent Res; 2014 Nov; 93(11):1141-7. PubMed ID: 25266715
[TBL] [Abstract][Full Text] [Related]
10. TRPV1 antagonists: the challenges for therapeutic targeting.
Khairatkar-Joshi N; Szallasi A
Trends Mol Med; 2009 Jan; 15(1):14-22. PubMed ID: 19097938
[TBL] [Abstract][Full Text] [Related]
11. A transient receptor potential-like channel mediates synaptic transmission in rod bipolar cells.
Shen Y; Heimel JA; Kamermans M; Peachey NS; Gregg RG; Nawy S
J Neurosci; 2009 May; 29(19):6088-93. PubMed ID: 19439586
[TBL] [Abstract][Full Text] [Related]
12. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
Knotkova H; Pappagallo M; Szallasi A
Clin J Pain; 2008 Feb; 24(2):142-54. PubMed ID: 18209521
[TBL] [Abstract][Full Text] [Related]
13. TRP channels in cancer pain.
de Almeida AS; Bernardes LB; Trevisan G
Eur J Pharmacol; 2021 Aug; 904():174185. PubMed ID: 34015320
[TBL] [Abstract][Full Text] [Related]
14. [Capsaicin receptor TRPV1].
Tominaga M
Brain Nerve; 2008 May; 60(5):493-501. PubMed ID: 18516971
[TBL] [Abstract][Full Text] [Related]
15. Beyond Hot and Spicy: TRPV Channels and their Pharmacological Modulation.
Seebohm G; Schreiber JA
Cell Physiol Biochem; 2021 May; 55(S3):108-130. PubMed ID: 34043299
[TBL] [Abstract][Full Text] [Related]
16. Medicinal Chemistry, Pharmacology, and Clinical Implications of TRPV1 Receptor Antagonists.
Aghazadeh Tabrizi M; Baraldi PG; Baraldi S; Gessi S; Merighi S; Borea PA
Med Res Rev; 2017 Jul; 37(4):936-983. PubMed ID: 27976413
[TBL] [Abstract][Full Text] [Related]
17. Modulation of TRPV1 channel function by natural products in the treatment of pain.
Abbas MA
Chem Biol Interact; 2020 Oct; 330():109178. PubMed ID: 32738201
[TBL] [Abstract][Full Text] [Related]
18. The TRPV1 receptor: target of toxicants and therapeutics.
Veronesi B; Oortgiesen M
Toxicol Sci; 2006 Jan; 89(1):1-3. PubMed ID: 16404782
[TBL] [Abstract][Full Text] [Related]
19. Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms.
Gunthorpe MJ; Szallasi A
Curr Pharm Des; 2008; 14(1):32-41. PubMed ID: 18220816
[TBL] [Abstract][Full Text] [Related]
20. Polymodal Transient Receptor Potential Vanilloid Type 1 Nocisensor: Structure, Modulators, and Therapeutic Applications.
Cui M; Gosu V; Basith S; Hong S; Choi S
Adv Protein Chem Struct Biol; 2016; 104():81-125. PubMed ID: 27038373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
